Table 1.
Results by Mode of Exercise (Hospital and Mixed Practice/Private Practice)
| Hospital/Mixed Practice (n= 175) | Liberal Practice (n=131) | Chi Square | |
|---|---|---|---|
| Prescription of methotrexate | 68.9% (n=115/167) | 34.6% (n=44/127) | ≤ 0.001 |
| MD: 8 | MD: 4 | ||
| Reason for not prescribing methotrexate | n=52 | n= 83 | |
| - Absence of eligible patients | −57.7% (n=30/52) | −39.8% (n=33/83) | |
| - No marketing authorisation for AD | −46.1% (n=24/52) | −48.2% (n=40/83) | |
| - No experience with methotrexate | −9.6% (n=5/52) | −34.9% (n=29/83) | |
| - Lack of training/information | −21.1% (n=11/52) | −50.6% (n=42/83) | |
| Prescription of cyclosporine | 75.1% (n=124/165) | 10.3% (n=13/126) | ≤ 0.001 |
| MD: 10 | MD: 5 | ||
| Reason for not prescribing cyclosporine | n= 41 | n=113 | |
|
−26.8% (n=11/41) | −23.9% (n=27/113) | |
|
−0 | −13.3% (n=15/113) | |
|
−78% (n=32/41) | −79.6% (n=90/113) | |
|
−41.5% (n=17/41) | −56.6% (n=64/113) | |
|
−4.9% (n=2/41) | −40.7% (n=46/113) | |
| Prescription of oral corticoids | 7.9% (n=13/164) | 12.1% (n=15/124) | NS |
| MD: 9 | MD: 7 | ||
| Prescription of dupilumab | 80.5% (n=132/167) | 25% (n=31/124) | ≤ 0.001 |
| MD: 8 | MD: 7 | ||
| Absence of use of score before methotrexate prescription | 39.5% (n=66/167) | 64.6% (n=82/127) | ≤ 0.001 |
| MD: 8 | MD: 4 | ||
| Absence of use of score before cyclosporine prescription | 35.1% (n=58/165) | 84.9% (n=107/126) | ≤ 0.001 |
| MD: 10 | MD: 5 |
Abbreviations: MD, missing data; AD, atopic dermatitis, NS, not significant.